Table 1.
Baseline Demographic and Clinical Information About Patients With Breast Cancer and Healthy Controls
| Variable | Control (n = 45) |
Chemotherapy (n = 60) |
No Chemotherapy (n = 72) |
Overall P | |||
|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | ||
| Age, years | .003 | ||||||
| Mean | 52.9 | 51.7 | 56.6 | ||||
| SD | 10 | 7.1 | 8.3 | ||||
| Range | 30-68 | 31-66 | 37-69 | ||||
| WRAT–3 raw score | .414 | ||||||
| Mean | 51.5 | 50.7 | 50.8 | ||||
| SD | 2.9 | 3.3 | 3.9 | ||||
| Range | 44-56 | 42-56 | 39-57 | ||||
| Education | .087 | ||||||
| Mean | 15.2 | 15.7 | 14.8 | ||||
| SD | 2.1 | 2.7 | 2.3 | ||||
| Range | 12-20 | 11-25 | 9-20 | ||||
| Ethnicity | |||||||
| White | 44 | 100 | 58 | 98 | 71 | 99 | .49 |
| Asian | 0 | 0 | 1 | 2 | 0 | 0 | |
| Other | 0 | 0 | 0 | 0 | 1 | 1 | |
| Ethnicity | |||||||
| Hispanic | 1 | 2 | 1 | 2 | 0 | 0 | .48 |
| Not Hispanic | 43 | 98 | 56 | 98 | 71 | 100 | |
| Menstrual status | |||||||
| Regular periods* | 14 | 32 | 16 | 27 | 16 | 24 | .62 |
| Irregular periods | 2 | 5 | 6 | 10 | 5 | 7 | |
| Stopped | 0 | 0 | 0 | 0 | 0 | 0 | |
| Begun to stop | 2 | 5 | 5 | 8 | 2 | 3 | |
| Stopped permanently | 26 | 59 | 32 | 54 | 45 | 66 | |
| CES–Depression | 5.1 | 3.6 | 10.9 | 8 | 8.3 | 7.3 | < .001 |
| STAI State Anxiety | 26.9 | 6.5 | 34.3 | 12.3 | 31.2 | 11.2 | .002 |
| FSI Fatigue | 1.7 | 1.2 | 2.6 | 1.7 | 2.2 | 1.6 | .011 |
Abbreviations: SD, standard deviation; WRAT-3, Wide Range Achievement Test (ed 3); CES-Depression, Center for Epidemiological Study-Depression; STAI State Anxiety, State-Trait Anxiety Inventory; FSI, Fatigue Symptom Inventory.
*
For longer than 1 year.